Spero Therapeutics, Inc. - Common Stock, par value $0.001 per share (SPRO)

CUSIP: 84833T103

Q1 2021 13F Holders as of 31 Mar 2021

Holder snapshot 7 signals
Share change
+824,228
Put/Call ratio
201%
SEC-reported price per share
$14.72
Number of holders
89
Value change
+$11,246,827
Number of buys
37
Open additional details 1 more signal available
Number of sells
34
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
55,705,828

Security key

84833T103

Report period

Q1 2021

Institutions

89

Top holders

10

Ownership snapshot

Top reported holders of SPRO - Spero Therapeutics, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Aquilo Capital Management...
Disclosed value leader
Aquilo Capital Management...
Comparable rows
0/15
Latest evidence
31 Dec 2020
13F Highest disclosed value: $76,246,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Aquilo Capital Management, LLC has the largest disclosed position value at $76.25M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Aquilo Capital Management, LLC's linked filing trail.
Disclosed position value Top 5
Aquilo Capital Management, LLC $76.25M
BVF INC/IL $43.5M
BlackRock Finance, Inc. $33.58M
Atlas Venture Associates IX, LLC $26.7M
Rock Springs Capital Management LP $23.95M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Aquilo Capital Management, LLC
13F
Company
13F
—
denominator unverified
$76,246,000
3,932,209 shares
— 31 Dec 2020
BVF INC/IL
13F
Company
13F
—
denominator unverified
$43,497,000
2,243,278 shares
— 31 Dec 2020
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$33,576,000
1,731,600 shares
— 31 Dec 2020
Atlas Venture Associates IX, LLC
13F
Company
13F
—
denominator unverified
$26,700,000
1,376,968 shares
— 31 Dec 2020
Rock Springs Capital Management LP
13F
Company
13F
—
denominator unverified
$23,947,000
1,235,000 shares
— 31 Dec 2020
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$21,925,000
1,130,730 shares
— 31 Dec 2020
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2021

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
89
Shares
18,548,675
Rows available
89
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2021 vs Q1 2021 Across Filers

Q1 2021 holders
89
Q1 2021 holders
89
Holder diff
0
Investor Q1 2021 Shares Q1 2021 Shares Share Diff Share Chg % Q1 2021 value Q1 2021 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .